Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Keith A. Goldan

Tracked across 1 events · 7 articles · First seen Apr 07, 2026 · Last active Apr 07, 2026

Sentiment
20
Attention
2
Events
1
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
2 20
Business
Keith A. Goldan was appointed as an independent member to the Board of Directors of Abeona Therapeutics Inc. and will serve as Chairman of its Audit Committee. His extensive financial leadership experience in the biotechnology and pharmaceutical sectors is expected to be invaluable in guiding Abeona's strategic and financial growth.
Apr 07, 2026 · 7 articles
100 Keith A. Goldan joined Board of Directors and became Audit Committee Chairman Abeona TherapeuticsAbeona Therapeutics...
100 Abeona Therapeutics appointed new independent board member and Audit Committee Chairman Keith A. GoldanAbeona Therapeutics...
Syndax Pharmaceuticals Chief Financial Officer Keith A. Goldan Keith A. Goldan is currently the Chief Financial Officer of Syndax Pharmaceutica
Abeona Therapeutics Board Member Keith A. Goldan Keith A. Goldan is an independent member of the Board of Directors of Abeona The
NEWSDESK
Track Keith A. Goldan live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.